Grosshans DR, Mohan R, Gondi V, Shih HA, Mahajan A, Brown PD. The role of image-guided intensity modulated proton therapy in glioma. Neuro Oncol. 2017;19(suppl_2):ii30-ii7.

Paganetti H, Beltran C, Both S, Dong L, Flanz J, Furutani K, et al. Roadmap: proton therapy physics and biology. Phys Med Biol. 2021;66(5). Discussion of the current state and future directions to improve proton treatment delivery by addressing treatment planning and delivery, imaging and patient selection.

Giovannini G, Bohlen T, Cabal G, Bauer J, Tessonnier T, Frey K, et al. Variable RBE in proton therapy: comparison of different model predictions and their influence on clinical-like scenarios. Radiat Oncol. 2016;11:68. Proton therapy relative biologic effectiveness and their clinical impact.

Oden J, Toma-Dasu I, Witt Nystrom P, Traneus E, Dasu A. Spatial correlation of linear energy transfer and relative biological effectiveness with suspected treatment-related toxicities following proton therapy for intracranial tumors. Med Phys. 2020;47(2):342-51. Proton therapy relative biologic effectiveness and associated treatment toxicities.

Paganetti H. Mechanisms and review of clinical evidence of variations in relative biological effectiveness in proton therapy. Int J Radiat Oncol Biol Phys. 2022;112(1):222–36.

Article  PubMed  Google Scholar 

Mailhot Vega R, Kim J, Hollander A, Hattangadi-Gluth J, Michalski J, Tarbell NJ, et al. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer. 2015;121(10):1694-702. Cost-benefit study for upfront proton beam therapy versus lifelong reduction of chronic medical complications in children.

Lundkvist J, Ekman M, Ericsson SR, Jönsson B, Glimelius B. Cost-effectiveness of proton radiation in the treatment of childhood medulloblastoma. Cancer. 2005;103(4):793-801. Cost-effectiveness study of proton beam therapy in the treatment of childhood medulloblastoma.

Kamran SC, Dworkin M, Niemierko A, Bussiere M, Oh KS, Loeffler JS, et al. Patterns of failure among patients with low-grade glioma treated with proton radiation therapy. Pract Radiat Oncol. 2019;9(4):e356–61.

Article  PubMed  Google Scholar 

Iannalfi A, D’Ippolito E, Riva G, Molinelli S, Gandini S, Viselner G, et al. Proton and carbon ion radiotherapy in skull base chordomas: a prospective study based on a dual particle and a patient-customized treatment strategy. Neuro Oncol. 2020;22(9):1348–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown PD, Chung C, Liu DD, McAvoy S, Grosshans D, Al Feghali K, et al. A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma. Neuro Oncol. 2021;23(8):1337–47.

Article  PubMed  PubMed Central  Google Scholar 

Yang JT, Wijetunga NA, Pentsova E, Wolden S, Young RJ, Correa D, et al. Randomized phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis. J Clin Oncol. 2022;40(33):3858–67.

Article  CAS  PubMed  Google Scholar 

THERAPY AMP-PB. ASTRO MODEL POLICIES - PROTON BEAM THERAPY. 2017. https://www.astro.org/uploadedFiles/_MAIN_SITE/Daily_Practice/Reimbursement/Model_Policies/Content_Pieces/ASTROPBTModelPolicy.pdf. Accessed 26 Feb 2023. ASTRO Model Policy summary of the evidence and rationale to support the use of proton beam therapy in the CNS and other tumour sites, based on clinical published data.

Tabrizi S, Yeap BY, Sherman JC, Nachtigall LB, Colvin MK, Dworkin M, et al. Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade glioma. Radiother Oncol. 2019;137:95–101.

Article  PubMed  PubMed Central  Google Scholar 

Baumann BC, Mitra N, Harton JG, Xiao Y, Wojcieszynski AP, Gabriel PE, et al. Comparative effectiveness of proton vs photon therapy as part of concurrent chemoradiotherapy for locally advanced cancer. JAMA Oncol. 2020;6(2):237–46.

Article  PubMed  Google Scholar 

Weber DC, Langendijk JA, Grau C, Thariat J. Proton therapy and the European Particle Therapy Network: the past, present and future. Cancer Radiother. 2020;24(6-7):687-90. Summary paper on the issue of proton therapy in Europe, discussion of approaches to PBT uptake including the Dutch model-based approach, and briefly discusses new proton prospective trials in Europe.

De Roeck L, van der Weide HL, Eekers DBP, Kramer MC, Alapetite C, Blomstrand M, et al. The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation. Radiother Oncol. 2022;168:241–9.

Article  PubMed  Google Scholar 

Langendijk JA, Boersma LJ, Rasch CRN, van Vulpen M, Reitsma JB, van der Schaaf A, et al. Clinical trial strategies to compare protons with photons. Semin Radiat Oncol. 2018;28(2):79–87.

Article  PubMed  Google Scholar 

McMaster ML, Goldstein AM, Bromley CM, Ishibe N, Parry DM. Chordoma: incidence and survival patterns in the United States, 1973–1995. Cancer Causes Control. 2001;12(1):1–11.

Article  CAS  PubMed  Google Scholar 

Soule E, Baig S, Fiester P, Holtzman A, Rutenberg M, Tavanaiepour D, et al. Current management and image review of skull base chordoma: what the radiologist needs to know. J Clin Imaging Sci. 2021;11:46.

Article  PubMed  PubMed Central  Google Scholar 

Hruban RH, Traganos F, Reuter VE, Huvos AG. Chordomas with malignant spindle cell components. A DNA flow cytometric and immunohistochemical study with histogenetic implications. Am J Pathol. 1990;137(2):435–47.

George B, Bresson D, Herman P, Froelich S. Chordomas: a review. Neurosurg Clin N Am. 2015;26(3):437–52.

Article  PubMed  Google Scholar 

Jawad MU, Scully SP. Surgery significantly improves survival in patients with chordoma. Spine (Phila Pa 1976). 2010;35(1):117–23.

Carpentier A, Polivka M, Blanquet A, Lot G, George B. Suboccipital and cervical chordomas: the value of aggressive treatment at first presentation of the disease. J Neurosurg. 2002;97(5):1070–7.

Article  PubMed  Google Scholar 

Stacchiotti S, Sommer J. Building a global consensus approach to chordoma: a position paper from the medical and patient community. Lancet Oncol. 2015;16(2):e71-83. Global consensus for the treatment of chordomas, a key document in the management of one of the few tumour sites to have a global consensus to treatment.

Weber DC, Malyapa R, Albertini F, Bolsi A, Kliebsch U, Walser M, et al. Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy. Radiother Oncol. 2016;120(1):169–74.

Article  PubMed  Google Scholar 

Palm RF, Oliver DE, Yang GQ, Abuodeh Y, Naghavi AO, Johnstone PAS. The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: an analysis of the National Cancer Data Base. Cancer. 2019;125(4):642–51.

Article  CAS  PubMed  Google Scholar 

Walser M, Bojaxhiu B, Kawashiro S, Tran S, Beer J, Leiser D, et al. Clinical outcome of sacral chordoma patients treated with pencil beam scanning proton therapy. Clin Oncol (R Coll Radiol). 2021;33(12):e578–85.

Article  CAS  PubMed  Google Scholar 

Kroesen M, Miladinovic V, Hutschemaekers SAJ, Jacobs J, van der Vos C, Wolf AL, et al. Single-institution clinical experience using robust intensity modulated proton therapy in chordoma and chondrosarcoma of the mobile spine and sacrum: feasibility and need for plan adaptation. Radiother Oncol. 2022;166:58–64.

Article  CAS  PubMed  Google Scholar 

Nabors LB, Portnow J, Ahluwalia M, Baehring J, Brem H, Brem S, et al. Central nervous system cancers, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020;18(11):1537–70.

Mercado CE, Holtzman AL, Rotondo R, Rutenberg MS, Mendenhall WM. Proton therapy for skull base tumors: a review of clinical outcomes for chordomas and chondrosarcomas. Head Neck. 2019;41(2):536–41.

PubMed  Google Scholar 

Strauss SJ, Frezza AM, Abecassis N, Bajpai J, Bauer S, Biagini R, et al. Bone sarcomas: ESMO-EURACAN-GENTURIS-ERN PaedCan Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(12):1520–36.

Article  CAS  PubMed  Google Scholar 

Rosenberg AE, Nielsen GP, Keel SB, Renard LG, Fitzek MM, Munzenrider JE, et al. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma. Am J Surg Pathol. 1999;23(11):1370–8.

Article  CAS  PubMed  Google Scholar 

Noël G, Feuvret L, Ferrand R, Boisserie G, Mazeron JJ, Habrand JL. Radiotherapeutic factors in the management of cervical-basal chordomas and chondrosarcomas. Neurosurgery. 2004;55(6):1252–60; discussion 60–2.

Amichetti M, Amelio D, Cianchetti M, Enrici RM, Minniti G. A systematic review of proton therapy in the treatment of chondrosarcoma of the skull base. Neurosurg Rev. 2010;33(2):155–65.

Article  PubMed  Google Scholar 

Whittle IR, Smith C, Navoo P, Collie D. Meningiomas. Lancet. 2004;363(9420):1535-43.

Oya S, Kim SH, Sade B, Lee JH. The natural history of intracranial meningiomas. J Neurosurg. 2011;114(5):1250–6.

Article  PubMed  Google Scholar 

Boehling NS, Grosshans DR, Bluett JB, Palmer MT, Song X, Amos RA, et al. Dosimetric comparison of three-dimensional conformal proton radiotherapy, intensity-modulated proton therapy, and intensity-modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiat Oncol Biol Phys. 2012;82(2):643–52.

Article  PubMed  Google Scholar 

Savla B, Alexander G, Pollock AE, Cohen J, Mishra MV. Opportunities and advances in the use of proton radiotherapy for management of central nervous system and base of skull tumors. Adv Oncol. 2022;2(1):1–11.

Article  Google Scholar 

Seidensaal K, Sailer J, Harrabi SB, von Gehlen J, Seidensaal I, Weykamp F, et al. The patient’s perspective on proton radiotherapy of skull base meningioma: a retrospective cross-sectional survey. Front Oncol. 2022;12: 677181.

Article  PubMed  PubMed Central  Google Scholar 

Stade F, Dittmar JO, Jakel O, Kratochwil C, Haberkorn U, Debus J, et al. Influence of (68)Ga-DOTATOC on sparing of normal tissue for radiation therapy of skull base meningioma: differential impact of photon and proton radiotherapy. Radiat Oncol. 2018;13(1):58.

Article  PubMed  PubMed Central  Google Scholar 

Noël G, Bollet MA, Calugaru V, Feuvret L, Haie-Meder C, Dhermain F, et al. Functional outcome of patients with benign meningioma treated by 3D conformal irradiation with a combination of photons and protons. Int J Radiat Oncol Biol Phys. 2005;62(5):1412–22.

Article  PubMed  Google Scholar 

Wenkel E, Thornton AF, Finkelstein D, Adams J, Lyons S, De La Monte S, et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys. 2000;48(5):1363–70.

Article  CAS  PubMed  Google Scholar 

Vernimmen FJ, Harris JK, Wilson JA, Melvill R, Smit BJ, Slabbert JP. Stereotactic proton beam therapy of skull base meningiomas. Int J Radiat Oncol Biol Phys. 2001;49(1):99–105.

Article  CAS  PubMed  Google Scholar 

Holtzman AL, Rotondo RL, Rutenberg MS, Indelicato DJ, Mercado CE, Rao D, Tavanaiepour D, Morris CG, Louis D, Flampouri S, Mendenhall WM. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study. J Neurooncol. 2019;142(3):557–563

Slater JD, Loredo LN, Chung A, Bush DA, Patyal B, Johnson WD, et al. Fractionated proton radiotherapy for benign cavernous sinus meningiomas. Int J Radiat Oncol Biol Phys. 2012;83(5):e633-7.

Article  PubMed  Google Scholar 

Weber DC, Bizzocchi N, Bolsi A, Jenkinson MD. Proton therapy for intracranial meningioma for the treatment of primary/recurrent disease including re-irradiation. Front Oncol. 2020;10: 558845.

Article  PubMed  PubMed Central  Google Scholar 

Sherman JC, Colvin MK, Mancuso SM, Batchelor TT, Oh KS, Loeffler JS, et al. Neurocognitive effects of proton radiation therapy in adults with low-grade glioma. J Neurooncol. 2016;126(1):157–64.

Article  CAS  PubMed  Google Scholar 

Jaspers JPM, Méndez Romero A, Wiggenraad R, Compter I, Eekers DBP, Nout RA, et al. Pattern of failure in IDH mutated, low grade glioma after radiotherapy & #x2013; Implications for margin reduction. Radiother Oncol. 2021;156:43–8.